Cargando…

Pan-Cancer Analysis of Pentraxin 3: A Potential Biomarker of COVID-19

SIMPLE SUMMARY: We clarified the expression patterns, genetic alterations, prognostic significance, and the underlying mechanisms of the COVID-19 biomarker PTX3 across TCGA cancers. Importantly, we linked PTX3 to immunotherapy, synthetically underscoring its importance in human cancers and providing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zijian, Zhou, Xuan, Yang, Yuanyuan, Wang, Lujia, Wu, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496739/ https://www.ncbi.nlm.nih.gov/pubmed/36139597 http://dx.doi.org/10.3390/cancers14184438

Ejemplares similares

Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
por: Zhou, Zijian, et al.
Publicado: (2022)

Serum Pentraxin 3 as Promising Biomarker for the Long-Lasting Inflammatory Response of COVID-19
por: Capra, Anna Paola, et al.
Publicado: (2023)

Pentraxin 3 (PTX-3) Levels in Bronchoalveolar Lavage Fluid as a Lung Cancer Biomarker
por: Hu, Tinghua, et al.
Publicado: (2020)

Elevated ovarian pentraxin 3 in polycystic ovary syndrome
por: Pan, Jiexue, et al.
Publicado: (2021)

Pentraxin 3: A Novel Biomarker for Inflammatory Cardiovascular Disease
por: Inoue, Kenji, et al.
Publicado: (2012)

Serum pentraxin 3 as a biomarker for prognosis of acute minor stroke due to large artery atherosclerosis
por: Zhang, Yan, et al.
Publicado: (2020)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

Genetic Variants Involved in the Crystallization Pathway Are Associated with Calcium Nephrolithiasis in the Chinese Han Population
por: Wang, Lujia, et al.
Publicado: (2022)

A Genetic Polymorphism in the WDR72 Gene is Associated With Calcium Nephrolithiasis in the Chinese Han Population
por: Wang, Lujia, et al.
Publicado: (2022)

Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
por: Wang, Yanghao, et al.
Publicado: (2023)

The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia
por: GENÇ, Ahmed Bilal, et al.
Publicado: (2021)

The pathogenicity of COVID-19 and the role of pentraxin-3: An updated review study
por: Margiana, Ria, et al.
Publicado: (2022)

Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
por: Liu, Siguan, et al.
Publicado: (2014)

Pentraxin-3 and inflammatory biomarkers related to posterolateral thoracotomy in Thoracic Surgery
por: Dongel, Isa, et al.
Publicado: (2019)

Regulation of pentraxin-3 by antioxidants
por: Hill, A. L., et al.
Publicado: (2009)

Pentraxin 3 in Cardiovascular Disease
por: Ristagno, Giuseppe, et al.
Publicado: (2019)

Pentraxin 3 contributes to neurogenesis after traumatic brain injury in mice
por: Zhou, Chao, et al.
Publicado: (2020)

Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells
por: Ronca, Roberto, et al.
Publicado: (2021)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

Comprehensive Multiomics Analysis Identified IQGAP3 as a Potential Prognostic Marker in Pan-Cancer
por: Wang, Guoqing, et al.
Publicado: (2022)

Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy
por: Zhu, Hong, et al.
Publicado: (2017)

Long pentraxin 3 as a marker of COVID-19 severity: evidences and perspectives
por: Assandri, Roberto, et al.
Publicado: (2022)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD
por: Thulborn, Samantha J, et al.
Publicado: (2017)

Pentraxin-3, Interleukin-6, and Acute Appendicitis: Biomarkers That Need Further Exploration
por: Abouhamda, Ayman
Publicado: (2020)

Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis?
por: Balbaloglu, Ozlem, et al.
Publicado: (2019)

Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions
por: Sharma, Anita, et al.
Publicado: (2021)

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Goulart, Michelle R., et al.
Publicado: (2021)

The Assessment of Pentraxin 3: A Novel Biomarker in Early Detection of Infection in Newborns
por: Baumert, Małgorzata, et al.
Publicado: (2021)

Insights into the Relationship between Pentraxin-3 and Cancer
por: Bogdan, Maria, et al.
Publicado: (2022)

Promoting role of pentraxin-3 in esophageal squamous cell carcinoma
por: Fan, Zhirui, et al.
Publicado: (2022)

Pentraxin 3: An Immuno-Regulator in the Lungs
por: Balhara, Jyoti, et al.
Publicado: (2013)

Serum pentraxin 3 concentrations in neonates
por: Lannergård, Anders, et al.
Publicado: (2014)

The role of pentraxin 3 in pemphigus vulgaris
por: Halil Yavuz, Ibrahim, et al.
Publicado: (2019)

Pentraxin 3: A Potential Novel Predictor for Neonatal Pulmonary Hypertension
por: Wakeel, Maged A. El, et al.
Publicado: (2019)

Utility of Pentraxin-3 as a biomarker for diagnosis of acute appendicitis: a systematic review and meta-analysis
por: Anand, Sachit, et al.
Publicado: (2022)

An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
por: Feng, Mingtao, et al.
Publicado: (2022)

Human Pentraxin 3 (PTX3) as a Novel Biomarker for the Diagnosis of Pulmonary Arterial Hypertension
por: Tamura, Yuichi, et al.
Publicado: (2012)

Association of polymorphisms in long pentraxin 3 and its plasma levels with COVID-19 severity
por: Feitosa, Thiala Alves, et al.
Publicado: (2022)

PENTRAXIN 3 LEVELS CORRELATE WELL WITH DISEASE SEVERITY AT ADMISSION IN COVID-19 PATIENTS
por: Işık, Mehmet Emirhan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i5mlhl1volgtl03d8c70tt8obo